Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer

PURPOSE: To determine, by molecular imaging, how in vivo pharmacodynamics of estrogen-estrogen receptor (ER) binding differ between types of standard endocrine therapy. EXPERIMENTAL DESIGN: The estrogen receptor (ER) has been a highly successful target for breast cancer treatment. ER-directed treatm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Linden, Hannah M., Kurland, Brenda F., Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Ellis, Georgiana K., Lawton, Thomas, Livingston, Robert B., Petra, Philip H., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139698/
https://ncbi.nlm.nih.gov/pubmed/21750198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-3321
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg